In Brief
Wei et al. show that the fission yeast protein Rrp2 safeguards the genome from damage induced by chemicals poisoning DNA topoisomerase II (Top2), such as the anti-cancer drug etoposide. Rrp2 binds the SUMO-modified form of Top2 and prevents it from being ubiquitinated by the SUMO-targeted ubiquitin ligase (STUbL).
INTRODUCTION
DNA topoisomerase II (Top2) plays important roles in DNA replication, transcription, and chromosome segregation by solving DNA topological problems (Nitiss, 2009a) . Top2 dimer cleaves both strands of a DNA duplex through a transesterification reaction, thus forming a covalent DNA-protein complex, called the Top2 cleavage complex (Top2cc). Normally, Top2ccs only exist transiently because their formation is followed quickly by another transesterification reaction that results in DNA religation. However, certain chemicals such as the anti-cancer drug etoposide (ETOP) inhibit religation and increase the levels of Top2cc (Nitiss, 2009b) . These chemicals are called Top2 poisons. Top2ccs are not dangerous per se, as the underlying DNA breaks are concealed and reversible. Genotoxicity arises through the processing of Top2ccs into exposed protein-free DNA breaks (Nitiss, 2009b; Yan et al., 2016) . One type of Top2cc-processing mechanism involves the proteasome-mediated degradation of Top2, believed to be triggered by collision of Top2ccs and RNA polymerase complexes moving along DNA (Mao et al., 2001; Yan et al., 2016) . Top2cc processing presumably needs to be tightly controlled to avoid inadvertent genomic stress. However, it is unclear whether and how Top2 is protected from harmful degradation events.
Many known Top2 poisons are natural compounds of plant and microbial origins (Bailly, 2012; Ketron and Osheroff, 2014) . Some of them, such as flavonoids, are common and abundant secondary metabolites. Therefore, a wide range of organisms, including humans, are often exposed to Top2 poisons through contact or dietary consumption (Marko and Boege, 2016) . The budding yeast Saccharomyces cerevisiae and the fission yeast Schizosaccharomyces pombe, from which significant insights into Top2 poisons have been gleaned (Hartsuiker et al., 2009; Malik and Nitiss, 2004; Nitiss and Wang, 1988) , co-inhabit with plants and soil microorganisms and hence likely have evolved mechanisms defending against Top2 poisons. However, owing to poor intracellular retention of commonly used Top2 poisons such as ETOP, the genetic screening power of S. pombe has yet to be exploited in full (Arita et al., 2011; Malik and Nitiss, 2004) .
In this work, we took advantage of a drug-sensitizing background to screen a fission yeast deletion library for ETOP sensitivity. This screen revealed a prominent role of a DNA translocase Rrp2 in protecting the genome from Top2-poison-induced DNA damage. We demonstrate that preventing SUMOylated Top2 from untimely degradation is the mechanism by which Rrp2 defends against Top2 poisons.
RESULTS
rrp2D Renders Fission Yeast Cells Specifically Sensitive to the Genotoxic Effect of ETOP S. pombe is insensitive to ETOP (Malik and Nitiss, 2004) but can be made sensitive by deleting the drug efflux pump gene pmd1 (Arita et al., 2011) . The ETOP sensitivity of pmd1D is exacerbated by Top2 over-expression, indicating that, like in other organisms, the target of ETOP in fission yeast is Top2 (Arita et al., 2011) . To identify genes that contribute to ETOP resistance, we crossed pmd1D into a pooled S. pombe deletion library and performed ETOP sensitivity screening using the barcode sequencing method (Han et al., 2010) (Figures 1A and 1B ; Table S1 ). As Table S1 for the growth inhibition score of each mutant. Higher scores indicate stronger ETOP sensitivity. Genes within 500 kb of the pmd1 gene are removed to account for the linkage effect. (C) An enrichment plot of a gene set enrichment analysis (GSEA) showing that genes in the gene set RESPONSE_TO_DNA_DAMAGE_STIMULUS are enriched among the ETOP-sensitive mutants (normalized enrichment score [NES] = 1.83, FDR q value = 0.013).
(legend continued on next page) expected, DNA damage response (DDR) genes are enriched among the ETOP-sensitive mutants ( Figure 1C) . Interestingly, the top-scoring DDR gene is rrp2, which encodes an SNF2-family DNA translocase and is only known to play a minor role in homologous recombination (Dziadkowiec et al., 2009 (Dziadkowiec et al., , 2013 . rrp2D was previously shown to be insensitive to genotoxins including UV, hydroxyurea (HU), camptothecin (CPT), ionizing radiation (IR), 4-nitroquinoline 1-oxide (4NQO), cisplatin, and methyl methanesulfonate (MMS) (Dziadkowiec et al., 2009) .
We independently deleted rrp2 in the pmd1D background, and the resulting strain exhibited strong ETOP sensitivity (Figure S1A) . Deletion of rrp1, which encodes a paralog of Rrp2 (Dziadkowiec et al., 2009 (Dziadkowiec et al., , 2013 , caused no ETOP sensitivity in the pmd1D background, nor did it enhance the ETOP sensitivity of pmd1D rrp2D ( Figure S1A ). As reported before, deleting rrp2 caused no sensitivity to MMS, CPT, HU, or UV ( Figure S1B ).
To determine whether the ETOP sensitivity of rrp2D is related to DNA damage, we used Rad52 foci as readout to assess the level of DNA damage ( Figure 1D ). More Rad52 foci were observed in pmd1D rrp2D cells than in pmd1D cells upon ETOP treatment, but not when cells were treated with IR or CPT.
Key players of the homologous recombination (HR) pathway, including the Mre11-Rad50-Nbs1 (MRN) complex and Ctp1, are important for fission yeast to survive Top2-poison-induced DNA damage (Hartsuiker et al., 2009; Malik and Nitiss, 2004) . MRN and Ctp1 also contribute to the nucleolytic processing of Top2ccs (Hartsuiker et al., 2009) . rrp2D enhanced the ETOP sensitivity of mre11D, rad50D, and ctp1D ( Figure 1E ), indicating that Rrp2 functions independently of HR and MRN-Ctp1-mediated Top2cc removal.
Attenuating SUMO Modification Suppresses the Top2
Poison Sensitivity of rrp2D To understand the mechanisms underlying the ETOP sensitivity of rrp2D, we performed suppressor screens (see STAR Methods). Remarkably, the suppressor mutations that we identified occurred either in genes encoding SUMO modification enzymes including E1 (Rad31 and Fub2), E2 (Hus5), and E3 (Pli1), or in nup132 and cdc48, two genes that have functional connections with SUMO modification (Nie et al., 2012; Nie and Boddy, 2015) . Among the suppressor genes, pli1 and nup132 are non-essential. Deleting either of them strongly suppressed the ETOP sensitivity and the Rad52 foci phenotype of rrp2D ( Figures  1F and 1G ). For the essential E1 and E2 genes, their point mutations identified in the mutagenesis screen, when re-created by knockin, suppressed the ETOP sensitivity of rrp2D ( Figure 1F ) and, like pli1D, reduced global SUMOylation ( Figure S1C ). Thus, the ETOP sensitivity of rrp2D can be suppressed by reducing SUMOylation.
To determine whether the suppressor mutations also increase ETOP resistance in the presence of Rrp2, we used the MDR-supML drug-hypersensitive strain background (Aoi et al., 2014) , which allowed us to assay ETOP sensitivity at lower drug concentrations than in the pmd1D background (Figure S1D ). Deleting pli1 made rrp2D but not rrp2 + cells more resistant to ETOP ( Figure S1E ), suggesting that the suppression effect is specific to rrp2D.
Sensitivities of fission yeast cells to two other Top2 poisons, idarubicin and doxorubicin, were also enhanced by rrp2D (Figures S1F and S1G) . Deleting pli1 made rrp2D but not rrp2 + cells more resistant to these drugs (Figures S1F and S1G).
Top2 SUMOylation Underlies the ETOP Sensitivity of rrp2D
Pli1 is a member of the PIAS/Siz family of SUMO E3 ligases. Its budding yeast homologs, Siz1 and Siz2, and its vertebrate homolog, PIASy, promote the SUMOylation of Top2 (Azuma et al., 2005; Takahashi et al., 2006) . Thus, we hypothesized that Pli1 may promote Top2 SUMOylation and thereby render rrp2D cells sensitive to Top2 poisons. S. pombe Top2 is indeed SUMOylated in vivo. Køhler et al. identified 22 (Køhler et al., 2015) , and we independently identified 16 SUMOylation sites on it, overlapping by 7 (Figures 2A; Table S2 ). One of the 9 sites uniquely identified in this study is K704 ( Figure S2A ), equivalent to K660 of Xenopus TOP2a; SUMOylation of K660 inhibits TOP2a activity (Ryu et al., 2010) .
To directly test whether S. pombe Top2 is a substrate of Pli1, we performed in vitro SUMOylation assay ( Figure 2B ). Top2 was moderately SUMOylated in the presence of mature SUMO (Pmt3GG), E1, and E2. Further addition of Pli1 substantially increased the fraction of SUMOylated Top2, especially higher-molecular-weight forms of Top2-SUMO conjugates. Previously, DNA was found to stimulate PIASy-mediated Top2a SUMOylation (Ryu et al., 2010) . Similarly, we found that DNA stimulated Top2 SUMOylation only when Pli1 was present.
Next, we examined whether ETOP affects Top2 SUMOylation. In vitro, incubating Top2, DNA, and ETOP together caused a mobility shift of Top2 on SDS-PAGE ( Figure S2B ). This shift is due to Top2cc formation, for it was abolished by DNase treatment or mutating Top2-Y835, the catalytic residue to which DNA is covalently attached (Figures S2B and S2C) . Interestingly, even when added at a level at which virtually all Top2 molecules were trapped on DNA, ETOP did not notably alter Top2 SUMOylation catalyzed by Pli1 ( Figure 2C , comparing lane 6 with 8).
If Top2 SUMOylation indeed is the underlying cause of the ETOP sensitivity of rrp2D, targeted deSUMOylation of Top2 should suppress this phenotype. As predicted, fusion of Ulp1(358-568)-the catalytic domain of S. pombe deSUMOylating enzyme Ulp1-to the C terminus of Top2 efficiently rescued ETOP sensitivity of rrp2D in a manner dependent on the enzymatic activity of Ulp1 ( Figures 2D and S2D ).
Rrp2 Interacts with SUMOylated Top2 through Its SUMO-Interacting Motifs
The data shown above suggest that Rrp2 prevents a deleterious consequence of Top2 SUMOylation. Thus, we next examined whether Rrp2 physically interacts with Top2 using immunoprecipitation (IP) analysis ( Figure 2E ). We found that higher molecular weight forms of Top2 were specifically co-IPed with Rrp2. These Rrp2-interacting forms of Top2 migrated more slowly when SUMO was tagged with an N-terminal His 10 tag and were diminished by pli1D, suggesting that Rrp2 is associated with SUMOylated Top2 generated by Pli1. Interestingly, Top2 in the IP up-shifted more than Top2 in the lysate, suggesting that Rrp2 preferentially interacts with more heavily SUMOylated forms of Top2.
GST pull-down assay showed that Rrp2 interacted with invitro-formed Top2-SUMO conjugates, especially those of higher molecular weight ( Figure 2F ). Truncation analysis indicated that the N-terminal 360-aa region of Rrp2 (Rrp2-N360) is both necessary and sufficient for binding to SUMOylated Top2.
Because Rrp2 did not bind to unmodified Top2 in the pulldown assay, we hypothesized that it may directly interact with SUMO. Indeed, in a yeast two-hybrid assay, full-length Rrp2 and Rrp2-N360, but not Rrp2 fragments missing the N360 region, interacted with the non-conjugatable form of SUMO (Pmt3-AA) ( Figure S2E ), suggesting that Rrp2-N360, predicted by DISOPRED3 to be an intrinsically disordered region (Jones and Cozzetto, 2015) , possesses SUMO-binding ability. Two software tools, GPS-SUMO and JASSA (Beauclair et al., 2015; Zhao et al., 2014) , predict that within Rrp2-N360 there are six SUMO-interacting motifs (SIMs), which we will refer to as SIM1-6 ( Figure 2G ). SIM3 and SIM5 are conserved across fission yeast species ( Figure 2G ), suggesting functional importance.
Further validating the Rrp2-SUMO interaction, SUMO chains generated in bacteria (Prudden et al., 2011) , especially the longer ones of four or more SUMO units, were efficiently pulled down by Rrp2 and Rrp2-N360 ( Figure 2H ). Their SUMO-chain-binding ability appeared to be on a par with that of Rfp1 and Rfp2, the SIM-containing subunits of fission yeast SUMO-targeted ubiquitin ligase (STUbL) (Prudden et al., 2007; Sun et al., 2007) . We disrupted SIMs in Rrp2-N360 by replacing the hydrophobic residues with alanines ( Figure 2G , using asterisks to denote such mutations). SUMO chain binding by Rrp2-N360 was moderately reduced by either SIM3* or SIM5* mutation and was strongly diminished when both SIM3 and SIM5 were mutated. Mutating all six SIMs decreased the binding to the background level. The effects of these mutations on SUMO chain binding in vitro directly correlated with their effects on Rrp2 function in vivo, i.e., an Rrp2 mutant that is more defective in SUMO chain binding is also more defective in its ability to rescue the ETOP sensitivity of rrp2D ( Figure 2I ), and the mutant proteins were not under-expressed ( Figure S2F ).
The N360 region is also important for the nuclear localization of Rrp2 ( Figure S2G ). When it was replaced with the SV40 NLS sequence (PKKKRKV) and two copies of SIM3 (DNAVIVVSDSESDD), the new version of Rrp2 fully rescued the ETOP sensitivity of rrp2D ( Figure 2I ). Replacing the N360 region with the NLS alone failed to generate a functional Rrp2. These results suggest that nuclear localization and SUMO binding are the only major functions of Rrp2-N360.
SUMOylated Top2 Undergoes Proteasome-Mediated Excessive Degradation in rrp2D
We hypothesized that Rrp2 may alleviate the genotoxic effect of Top2 SUMOylation by preventing the excessive accumulation of SUMOylated Top2. This model predicts that Top2 SUMOylation should increase in rrp2D. However, contrary to our prediction, the amount of Top2-SUMO conjugates in rrp2D, especially those with more than four SUMO molecules, decreased, albeit not to the extent seen in pli1D ( Figure 3A ). ETOP treatment did not alter this pattern ( Figure 3B ). We thus conclude that the ETOP sensitivity of rrp2D is not caused by accumulation of SUMOylated Top2. However, it cannot be caused by the lower level of SUMOylated Top2 either, because further decreasing Top2 SUMOylation by deleting pli1 rescued the ETOP sensitivity of rrp2D.
Seeking alternative explanations, we asked whether the sensitivity phenotype might result from excessive turnover of (Køhler et al., 2015) , sites identified only in this work, and sites identified in both works, respectively (see Table S2 for a detailed list of sites identified in this work). The catalytic residue Y835 is marked by a triangle. (B) Pli1 catalyzed in vitro SUMOylation of Top2. Mature SUMO (Pmt3GG) and SUMOylation enzymes were purified from E. coli. The substrate, YFP-FLAG-His 6 (YFH)-tagged Top2, was expressed under the Pnmt1 promoter and immunopurified from S. pombe. Reactions were performed at 30 C for 10 min.
(C) ETOP did not affect Top2 SUMOylation. ETOP caused the formation of covalent Top2-DNA complex (Top2cc), which has a low mobility on SDS-PAGE and is sensitive to DNase. A small amount of Top2cc formed without DNA addition (lane 3), probably due to DNA contamination in the Top2 preparation.
(D) Fusing Ulp1(358-568) to the C terminus of Top2 following mCherry (Top2-mCherry-Ulp1) rescued the ETOP sensitivity of pmd1D rrp2D. A Ulp1 catalytically inactive mutation (C527S, Top2-mCherry-Ulp1*) abolished this rescue effect.
(E) Rrp2 co-immunoprecipitated SUMOylated Top2. Top2 was endogenously tagged with 33HA. GFP or GFP-Rrp2 was expressed under the rrp2 promoter. A strain in which SUMO is tagged with a His 10 tag was used to determine whether the up-shifted bands of Top2 were its SUMOylated forms. Expression levels are shown in Figure S2F . See also Figure S2 and Table S2 .
Top2-SUMO conjugates. If this is true, the level of unmodified Top2 may decrease as an indirect consequence. Indeed, the amount of unmodified Top2 in the chromatin fraction decreased in rrp2D with or without ETOP treatment ( Figure 3C ). A lower level of chromatin-bound Top2 per se is unlikely to cause ETOP sensitivity, because when we reduced Top2 expression by placing it under weaker promoters, chromatin-bound Top2 also decreased, but cells became more, not less, resistant to ETOP ( Figures S3A and S3B ). In addition, the reduction of chromatin-bound Top2 in rrp2D was reversed by pli1D ( Figure 3D ). Together, these data support the idea that excessive turnover of SUMOylated Top2 occurs in rrp2D.
Besides pli1D, another suppressor of the ETOP sensitivity of rrp2D, cdc48-A439T, also restored chromatin-bound Top2 in rrp2D to the wild-type level ( Figure 3D ). Given that Cdc48 acts with the proteasome to degrade ubiquitinated proteins, we asked whether the phenotype of rrp2D can be suppressed by inhibiting the proteasome. Using the MDR-supML strain background (Aoi et al., 2014) , we examined the effect of a proteasome inhibitor bortezomib (BTZ) on ETOP-induced DNA damage (Figures 3E and S3C) , for the cytotoxicity of BTZ prevented cell growth assays. BTZ strongly reduced ETOP-induced Rad52 foci in rrp2D but had no effect on Rad52 foci induced by zeocin, which cleaves DNA directly. The effect of BTZ is unlikely to be due to the mitotic arrest it caused (Aoi et al., 2014) , because another mitosis-arresting drug, methyl 2-benzimidazole carbamate (MBC), did not affect Rad52 foci in rrp2D. These results support the idea that excessive proteasome-mediated degradation of SUMOylated Top2 in rrp2D leads to escalation of ETOPinduced DNA damage.
Genomic Stress Arising in the Absence of Rrp2 Is Caused by Top2cc Degradation
How does the degradation of Top2 lead to DNA damage? We hypothesized that Top2ccs, when degraded inadvertently, expose DNA breaks that are normally concealed. This model predicts that the catalytic activity of Top2 is necessary for the increase of ETOP-induced DNA damage in rrp2D. Because catalytically inactive Top2 does not support cell growth, we tested this prediction by using the lacO-LacI system to target exogenous Top2 to a specific genomic locus (Figures 3F and 3G (Germe et al., 2009) . We found that rrp2D top2-191 double mutant exhibited increased spontaneous Rad52 foci and cell elongation, phenotypes not observed with top2-191 and rrp2D single mutants (Figure S3D ). This shows that Rrp2 prevents genomic stress caused by the accumulation of Top2ccs, whether they are induced by Top2 poisons or not.
SUMOylated Top2 Undergoes Excessive Ubiquitination in rrp2D
We hypothesized that the increase of proteasome-mediated Top2 turnover in rrp2D may be a result of hyper-ubiquitination. Indeed, Top2-Ub conjugates increased in rrp2D, especially when Cdc48 function was perturbed ( Figure 3H ). ETOP treatment enhanced the accumulation of Top2-Ub conjugates. Deletion of pli1 diminished accumulation of Top2-Ub conjugates in rrp2D cdc48-353 ( Figure 3I ), suggesting that excessive Top2 ubiquitination in rrp2D mainly occurred on SUMOylated Top2. (E) Proteasome inhibitor BTZ reduced ETOP-induced, but not zeocin-induced, Rad52-YFP foci in rrp2D cells of the MDR-supML background. Cells were treated with 2 mg/mL ETOP or 5 mg/mL zeocin alone or in combination with 5 mM BTZ or 10 mg/mL MBC for 2 hr. Values are means of triplicates ± SD. Representative images are shown in Figure S3C . (F) Diagram depicting the lacO-LacI system used to concentrate Top2 at a specific genomic locus. (G) Top2-LacI targeted to the lacO repeat exhibited diminished focus formation in rrp2D and caused local DNA damage in a manner dependent on the catalytic residue Y835. Values are means of triplicates ± SD. (H) Top2 ubiquitination increased in rrp2D. Biotin-tagged ubiquitin (Biotin-Ub) was expressed from the Pnmt1 promoter and was immunoprecipitated with streptavidin beads. cdc48-353 cells were shifted to 37 C for 2 hr to inactivate Cdc48.
(I) pli1D diminished Top2 ubiquitination in rrp2D. Except for (E), strains used in this figure are in the pmd1D background, and ETOP treatment was performed by incubating with 50 mg/mL ETOP for 2 hr. See also Figure S3 . (A) Top2-43SUMO was ubiquitinated by Rfp1/2-Slx8 STUbL in a manner dependent on the SUMO chain fused to Top2 and the SIMs on STUbL. Ubiquitin and ubiquitination enzymes were purified from E. coli. The substrate, Top2-43SUMO or Top2, was expressed under the Pnmt1 promoter and immunopurified from S. pombe. Reactions were incubated at 30 C for 10 min.
(B) GST pull-down assay showing that Rfp1 and Rfp2, but not Rfp1-23SIM*, can bind to SUMO chains. (C) STUbL-mediated Top2-43SUMO ubiquitination was stimulated by DNA and ETOP.
(D) slx8-R247G rescued the ETOP sensitivity of pmd1D rrp2D.
(E) Slx8-R247G mutation weakened the STUbL activity of Rfp1-Slx8 toward GST-43SUMO.
(F) The E3 activity of Slx8-R247G-containing STUbL toward Top2-43SUMO was inhibited by DNA and ETOP. Reactions were carried out as in (A) and (C), except that the reaction time was 30 min instead of 10 min.
(legend continued on next page)
If caused by Top2 hyper-ubiquitination, the ETOP sensitivity of rrp2D should be suppressed by targeted de-ubiquitination of Top2. Adopting an established method (Liu et al., 2015) , we fused Top2 with Ubp7 or UL36, two de-ubiquitinating enzymes (DUBs), and found that the ETOP sensitivity of rrp2D was partially suppressed in a manner that required the DUB enzymatic activity ( Figure S3E ). These results support the notion that Rrp2 prevents excessive Top2 ubiquitination. One possible mechanism is that Rrp2 prevents the ubiquitination enzymes from modifying SUMOylated Top2.
STUbL Can Ubiquitinate SUMO-Chain-Fused Top2
In Vitro STUbLs preferentially modify SUMOylated proteins (Sriramachandran and Dohmen, 2014) . In fission yeast, the only known STUbL is the heterodimeric E3 enzyme Rfp1/Rfp2-Slx8 (Prudden et al., 2007; Sun et al., 2007) . Rfp1 and Rfp2 are redundant paralogs, and their counterpart in budding yeast is Slx5.
To determine whether STUbL can ubiquitinate SUMOylated Top2, we established an in vitro ubiquitination assay in which Top2 fused with 43SUMO was used as a mimetic of polySUMOylated Top2. A gel mobility shift of Top2-43SUMO occurred in a manner requiring ubiquitin, E1, E2, and both subunits of the STUbL E3, indicating that this gel shift was caused by ubiquitination ( Figure 4A ). Mutations disrupting the SIMs in Rfp1 prevented it from binding to poly-SUMO chains ( Figure 4B ) and ubiquitinating Top2-43SUMO ( Figure 4A ). Top2 without 43SUMO was not a substrate of Rfp1-Slx8 ( Figure 4A ). As such, our assay recapitulated the requirement of the SUMO-SIM interaction for the STUbL activity (Prudden et al., 2007; Sun et al., 2007) . Interestingly, Top2-43SUMO ubiquitination was enhanced by DNA and was further augmented by ETOP ( Figure 4C ). This result mirrored the observation that ETOP treatment increased Top2 ubiquitination in vivo ( Figure 3H) .
A Partial Loss-of-Function STUbL Mutant Renders Rrp2 Dispensable for ETOP Resistance If Rrp2 indeed acts by preventing STUbL from modifying SUMOylated Top2, reducing STUbL activity may alleviate the need for Rrp2. Because slx8 single deletion or rfp1 rfp2 double deletion causes lethality (Prudden et al., 2007; Sun et al., 2007) , we performed random mutagenesis on slx8 and screened for mutations that can suppress the ETOP sensitivity of rrp2D. The strongest suppressor we isolated-slx8-R247G-suppressed the ETOP sensitivity as effectively as pli1D (Figure 4D) . slx8-R247G also increased Top2-SUMO conjugates and chromatin-bound Top2 in rrp2D ( Figures S4A and S4B ) and decreased Top2 ubiquitination in rrp2D ( Figure S4C ).
Slx8-R247 is a conserved residue ( Figure S4D ). Its equivalent in mammalian STUbL protein RNF4 is involved in E2 binding and important for E3 activity (Plechanovová et al., 2011 (Plechanovová et al., , 2012 . We found that the Slx8-R247G mutation did not affect the formation of the STUbL complex ( Figure S4E ) but partially reduced the ubiquitination activity toward GST-4xSUMO, Top2-43SUMO, and the STUbL complex itself ( Figures 4E, 4F, and S4F) . Thus, the suppression of the ETOP sensitivity of rrp2D by slx8-R247G is probably due to a reduction of STUbL activity.
Interestingly, DNA stimulated the activity of wild-type STUbL but inhibited that of the mutant STUbL toward Top2-43SUMO, and this inhibition was further enhanced by ETOP ( Figure 4F ). To explain this phenomenon, we performed DNA-binding analysis and found that Slx8 and Rfp1 together exhibited a DNA-binding ability, which was diminished by the Slx8-R247G mutation ( Figure 4G ), consistent with Slx8-R247 being part of a conserved ''basic cluster'' motif important for DNA binding of human RNF4 ( Figure S4D ) (Groocock et al., 2014) . The opposite effects of DNA on wild-type and mutant STUbL were also observed when we used an artificial substrate GST-43SUMO-LacI paired with lacO repeat DNA ( Figure 4H ). Disrupting the LacI-lacO interaction by IPTG dampened both the stimulatory effect of DNA on wildtype STUbL and the inhibitory effect of DNA on mutant STUbL. Presumably, ubiquitination occurs most efficiently when both the substrate and the enzyme are concentrated on DNA. When only one of them is bound to DNA, the substrate is in effect sequestered away from the enzyme.
The diminished ability of mutant STUbL to modify DNA-associated substrates is expected to impact many STUbL-involved processes. Indeed, we found that the slx8-R247G mutant is sensitive to a wide range of genotoxins ( Figure S4G ).
The ATPase Activity but Not the RING Domain of Rrp2 Is Critical for Its Function To understand how Rrp2 may prevent the action of STUbL, we analyzed the consequences of mutating the conserved regions of Rrp2. Rrp2 harbors a RING domain and thus may potentially act as a ubiquitin E3 ligase. The budding yeast ortholog of Rrp2, Uls1/Ris1/Tid4/Dis1 (hereafter Uls1), has been proposed to be a STUbL (Uzunova et al., 2007) but without direct evidence of its E3 activity (Tan et al., 2013) . We failed to detect an E3 activity of Rrp2 on Top2-43SUMO under the condition where Rfp1-Slx8 and Rfp2-Slx8 exhibited robust activities ( Figure S5A ). In vivo, Rrp2 missing the entire RING domain (Rrp2-RINGD, i.e., 746-797D) or two conserved cysteines in the RING domain (Rrp2-2CA, i.e., C746AC749A) effectively rescued the ETOP sensitivity of rrp2D ( Figure 5A ). Rrp2-RINGD also rescued the other phenotypes of rrp2D, including the decrease of SUMOylated Top2 and chromatin-bound Top2 and the increase of ETOP-induced Rad52 foci (Figures S5B-S5D) . Thus, the RING domain is not required for the Top2-related functions of Rrp2.
As a member of the ATP-dependent Snf2 translocase family, Rrp2 may utilize its ATPase activity to prevent Top2 from being modified by STUbL. To test this idea, we introduced mutations into the Walker ATPase motifs. Both the Walker-A mutant (Rrp2-KA, i.e., K422A) and the Walker-B mutant (Rrp2-DEAA, (G) Slx8-R247G mutation disrupted STUbL-DNA binding. Proteins bound to biotinylated double-stranded DNA were pulled down by streptavidin beads and analyzed by immunoblotting with HA antibody. (H) In vitro ubiquitination of an artificial substrate, GST-43SUMO-LacI, by Rfp1-Slx8 was influenced by lacO repeat DNA and IPTG. See also Figure S4. i.e., D539AE540A) failed to rescue the ETOP sensitivity and other phenotypes of rrp2D ( Figures 5A and S5B-S5D ), even though their expression levels were similar to that of Rrp2-RINGD (Figure S5E) . Because Snf2-family translocases are known to displace proteins from DNA (Hopfner et al., 2012) , we hypothesized that Rrp2 may use its ATPase activity to reduce the chance of SUMOylated Top2 being trapped on chromatin as Top2cc and thus prevent STUbL-mediated Top2cc degradation. We next tested this possibility.
Rrp2 Displaces Top2-SUMO Conjugates from DNA through Its ATPase Activity
To circumvent the effect of STUbL-mediated degradation on the level of chromatin-bound Top2, we used a temperature-sensitive mutant, slx8-29, to inactivate STUbL (Nie et al., 2012; Prudden et al., 2011) (Figure S6A ). Unlike the situation when STUbL is active, the loss of Rrp2 in cells lacking STUbL activity caused an increase of chromatin-bound Top2 ( Figure 5B ). This phenotype was reversed by re-introducing Rrp2-wt and Rrp2-RINGD but not Rrp2-SIM(1-6)* and Rrp2-KA ( Figure 5C ). These results suggest that Rrp2 uses its SIMs and ATPase activity to displace SUMOylated Top2 from chromatin and, as a result, reduce the level of chromatin-bound Top2. Consistent with this idea, the level of Top2-SUMO conjugates increased in rrp2D slx8-29 double mutant compared to slx8-29 single mutant ( Figure 5D ), likely due to the increased chance of Top2 being modified on chromatin by Pli1.
To directly demonstrate that Rrp2 can displace SUMOylated Top2 from DNA, we performed an in vitro displacement assay, in which we used Top2-Y835F to avoid covalent linkage between Top2 and DNA ( Figure 5E ). In the presence of ATP, Rrp2 effectively displaced SUMOylated Top2, but not unmodified Top2, from DNA ( Figure 5E ). Rrp2-SIM(1-6)* and Rrp2-KA exhibited little displacement activity toward SUMOylated Top2 ( Figure 5F ). Substituting ATP with ATP-gS inhibited this activity ( Figure 5F ). Thus, Rrp2 acts as a protein displacement translocase in a SUMO-targeted manner.
Rrp2 Reduces ETOP-Induced Top2cc Formed by SUMO-Chain-Fused Top2
Top2cc formed in the presence of ETOP has a longer half-life but remains in a reversible equilibrium with Top2 non-covalently associated with DNA. We hypothesized that the Top2-displacing activity of Rrp2 may shift the equilibrium away from Top2cc. To test this idea, we performed in vitro Top2cc formation assay using Top2-43SUMO ( Figures 5G and S6B ). Rrp2 decreased Top2cc formed by Top2-43SUMO in a dose-dependent manner ( Figure 5H ). This activity relied on SIMs and the ATPase activity but not the RING domain (Figures 5I and 5J ). Substituting ATP with ATP-gS inhibited this activity ( Figure S6C ). The reversion of Top2cc after tethering ETOP-treated Top2-43SUMO to beads and washing away ETOP occurred at the same rate whether Rrp2 was present or not ( Figure S6D ), indicating that Rrp2 does not affect Top2cc through accelerating Top2cc reversion.
Rrp2 Competes against STUbL for SUMO Chain Binding
Given that Rrp2 can bind SUMO chains as strongly as Rfp1 and Rfp2 ( Figure 2H ), we wondered whether Rrp2 antagonizes STUbL by preventing it from binding substrates. However, SUMO chain binding may simply act as a targeting mechanism to bring Rrp2 to SUMOylated Top2. To test this possibility, we tethered Rrp2 to Top2 through the binding between GFP and the GFP-binding protein (GBP) and found that SIMs remained indispensable under such a circumstance ( Figure 6A ). Therefore, SIMs are more than a mere tether between Rrp2 and Top2.
We then directly tested whether Rrp2 can prevent STUbL from binding SUMOylated Top2. Indeed, Rrp2-wt and Rrp2-KA, but not Rrp2-SIM(1-6)*, effectively competed with Rfp1-Slx8 for binding to Top2-43SUMO ( Figure 6B ). Further, Rrp2-N360 dissociated SUMO chains from GST-Rfp1 and GST-Rfp2, whereas Rrp2-N360-SIM(1-6)* did not ( Figure 6C ). Thus, competing against STUbL for SUMO chain binding is another mechanism by which Rrp2 can prevent the action of STUbL.
Supporting the dual mechanism of action, we found that in the absence of DNA, Rrp2 inhibited the in vitro ubiquitination of Top2-43SUMO by STUbL in a SIM-dependent but ATPaseindependent manner, and in the presence of DNA, both SIMs and the ATPase activity contributed to the inhibition ( Figure 6D ). Uls1, the S. cerevisiae Ortholog of Rrp2, Also Functions in Protecting the Genome from Top2 Poisons Like fission yeast rrp2D mutant, budding yeast uls1D mutant is not sensitive to commonly used DNA damaging agents including HU, MMS, CPT, phleomycin, and UV (Kramarz et al., 2014) . To our knowledge, no small-scale studies have implicated Uls1 in Top2 poison resistance. However, through mining large-scale screening data, we found that uls1D mutant is sensitive to three Top2 poisons: idarubicin (Brown et al., 2006; Lee et al., 2014) , doxorubicin (Westmoreland et al., 2009), and NSC-638432 (Kapitzky et al., 2010) . Thus, like Rrp2, Uls1 is important for cells to survive exposure to Top2 poisons. To verify this, we examined whether deleting ULS1 causes ETOP sensitivity. In two drughypersensitive strain backgrounds, uls1D mutant exhibited sensitivity to ETOP ( Figure 7A ). Using Rad52 foci as readout for DNA damage, we found that uls1D mutant accumulated more DNA lesions than wild-type when treated with ETOP but not when treated with IR or CPT ( Figure 7B ). uls1D rad52D double mutant exhibited a stronger ETOP sensitivity than either single mutant ( Figure 7C ), suggesting that Uls1 functions independently of HR.
Uls1 has a domain organization similar to that of Rrp2 (Figure S7A) . We examined the ability of various Uls1 mutants to rescue the ETOP sensitivity of uls1D ( Figure 7D ). Uls1-(1330-1385)D (Uls1-RINGD) rescued uls1D fairly well, although not fully. In contrast, ATPase-defective mutants D1108AE1109A (Uls1-DEAA) and Uls1-K975A (Uls1-KA) had little or no rescuing activity and neither did NLS-Uls1-N914D, in which the SIMcontaining N-terminal region was replaced with an NLS. Adding back two copies of SIM3 from Rrp2 partially restored the function of NLS-Uls1-N914D. Therefore, like fission yeast Rrp2, budding yeast Uls1 relies on its ATPase activity and SUMO-binding ability to confer ETOP resistance.
Two more parallels were found between Uls1 and Rrp2. First, the ETOP sensitivity ( Figure 7E ) and the idarubicin sensitivity ( Figure S7B ) of uls1D were suppressed by deleting SIZ1 and SIZ2 that encode the Pli1 homologs. Second, a reduction of higher molecular weight Top2-SUMO conjugates was observed in uls1D ( Figure S7C ). Thus, like Rrp2, Uls1 prevents the deleterious consequence of SUMOylation-most likely the excessive turnover of SUMOylated Top2, which leads to the conversion of Top2ccs into exposed DNA breaks.
Published genetic studies have hinted that Uls1 can remove Rad51 and SUMOylated Rap1 from DNA (Chi et al., 2011; Lescasse et al., 2013) . We propose that, like fission yeast Rrp2, Uls1 may displace SUMOylated Top2 from DNA. In addition, it may more broadly antagonize STUbL-mediated degradation through SIM competition and removing STUbL substrates from DNA. In agreement with this idea, it was shown that Uls1 over-expression can suppress STUbL-dependent degradation of SUMOylated Mot1-301 protein (Tan et al., 2013) .
DISCUSSION
This study has unveiled a mechanism protecting the genome from Top2-induced DNA damage ( Figure 7F ). Even though it has been proposed that in mammalian cells Top2cc degradation causes genotoxicity (Yan et al., 2016) , it is surprising that yeast cells have evolved a mechanism that actively prevents the degradation of chromatin-bound SUMOylated Top2 even in the absence of Top2 poisons. Our study thus demonstrates that Top2 degradation activities, even those not specifically induced by Top2 poisons, may bring about deleterious consequences and need to be tightly controlled.
STUbLs have always been regarded as genome protectors (Jackson and Durocher, 2013; Sriramachandran and Dohmen, 2014) . Our study uncovers an unexpected genotoxic effect of a STUbL-mediated ubiquitination event and reveals a mechanism tailored to curtail such activity.
Rrp2 and Uls1 belong to the RING-domain-containing Rad5/ 16-like group of Snf2-family translocases (Flaus and OwenHughes, 2011) . There are three members of this group in humans: SHPRH, HLTF, and TTF2. A recent report showed that in chicken DT40 cells, which lack a HLTF ortholog, SHPRH knockout caused sensitivity to two different Top2 poisons, ETOP and doxorubicin, but did not alter sensitivity to several other genotoxins including MMS, cisplastin, and 4-NQO (Tomi et al., 2014) , raising the possibility that an Rrp2-like mechanism of genome protection against Top2 poisons may exist in vertebrate cells. Like Rrp2, the ETOP resistance function of SHPRH is independent of its RING domain (Tomi et al., 2014) .
Top2 poisons such as ETOP are mainstream anti-cancer drugs, and dietary uptake of Top2 poisons has been linked to human diseases such as infant leukemia and autism (Marko and Boege, 2016) . Therefore, the Top2 poison defense mechanism discovered here has potential implications for disease etiology and treatment.
STAR+METHODS
Detailed methods are provided in the online version of this paper and include the following: (A) uls1D cells exhibited ETOP sensitivity. ULS1 was deleted in a regular lab strain background and two drug-hypersensitive backgrounds (Chinen et al., 2011; Stepanov et al., 2008) . See also Figure S7 . 
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EXPERIMENTAL MODEL AND SUBJECT DETAILS
Yeast strains used in this study are listed in Table S3 . They were grown using standard practices.
METHOD DETAILS Strain and plasmid construction
Yeast strains used in this study are listed in Table S3 and plasmids used in this study are listed in Table S4 . The deletion strains used in this study were constructed by PCR-based gene targeting. Strains expressing proteins fused with different C-terminal tags (TAP, HA, GFP, CFP, etc.) under native promoters were constructed by PCR-based tagging. For the lacO-LacI system for Top2 recruitment, the lacO repeat was integrated into the terminator of erg7 gene. A plasmid expressing mCherry-LacI gene under the control of the dis1 promoter was integrated into the lys1 locus. Fission yeast Rad52 was C-terminally tagged with two tandem copies of CFP by plasmid integration. For the His 10 -Pmt3 expression, in a strain carrying the his3-D1 deletion allele, pmt3 was replaced with the his3 gene, and then the pHIS3K-Ptub1-His 10 -Pmt3 plasmid was integrated into the his3 gene at the pmt3 locus. In fission yeast, Top2 and Rrp2 (wt and mutants) expression plasmids were integrated at the leu1 or ars1 locus under Pnmt1 or their native promoters using modified pDUAL vectors. In budding yeast, Uls1 (wt and mutants) expression plasmids were integrated at the LEU2 locus under the PURA3 promoter using modified pNH605 vectors. Point mutations identified in the suppressor screen were re-created using PCR based gene targeting (for cdc48-A439T::kanMX) or CRISPR-Cas9 system (for SUMO-E1/E2 mutants). The catalytic domain of SpUlp1 (358-568) and corresponding catalytically inactive mutant (C527S) were fused at the C terminus of Top2-mCherry and expressed under the top2 promoter from pDUAL-based plasmids, which were integrated at the leu1 locus. The Ubp7 and UL36 DUBs and corresponding catalytically inactive versions were as described (Liu et al., 2015) . DUBs were fused at the C terminus of Top2-mCherry and expressed under the top2 promoter from pDUAL-based plasmids, which were integrated at the leu1 locus.
ETOP sensitivity screen
To introduce pmd1 deletion into the deletion library strains, frozen aliquots of Bioneer version 1.0 deletion strain pool (Han et al., 2010) were thawed and recovered in YES liquid medium for 12 hr before being mixed with ade6-M210) cells at 1:1.5 ratio and spotted on SPAS plates on which mating and sporulation can occur. After incubation at 25 C for 4 days, spores were purified by centrifugation on a Percoll gradient. To enrich for progeny cells that harbor ura4 + -marked pmd1 deletion, spores were inoculated at a concentration of 10 6 spores/ml into uracil-free PMG liquid medium that allows Ura + but not Ura -spores to germinate. The culture was maintained in log phase for 40 hr. Afterward, cells were collected by centrifugation and washed with fresh YES liquid medium twice, and then resuspended at a concentration of OD600 = 0.05 in YES liquid medium. The culture was split into two, with one half treated with ETOP (Sigma Aldrich) at a concentration of 100 mg/ml and the other half untreated. Cultures were harvested after five OD600 doublings and barcode sequencing analysis was performed as described (Han et al., 2010) . The Illumina sequencing data have been deposited at NCBI SRA under the accession number SRX2041103.
For gene set enrichment analysis (GSEA), the gene list ranked by growth inhibition scores was analyzed using the preranked tool of GSEA v2.2.2. The GO-derived MSigDB format gene sets were downloaded from the GO2MSIG website (http://www.go2msig. org/cgi-bin/prebuilt.cgi?taxid=284812). The ''high quality GO annotations only'' gene sets of April 2015 were used.
Drug sensitivity assay (spot assay)
Five-fold dilutions of the indicated strains were spotted on plates without drug (No treatment), or plates containing drugs at the indicated concentrations. Plates were incubated at 30 C. Photos were taken 48 hr later, if not otherwise indicated.
Suppressor screen using the deletion library The deletion strain pool was mixed with DY19841 cells and spotted on SPAS plates to allow mating and sporulation to occur. Spores were purified and plated at a concentration of 10 6 spores per plate on YES plates containing G418, clonNAT, and hygromycin to select progenies harboring the library-derived gene deletion marked by kanMX, pmd1D marked by natMX, and rrp2D marked by hphMX. Spores were also plated on YES plates containing ETOP in addition to the three antibiotics. Deletions in the ETOP-resistant colonies were identified by sequencing the barcodes.
Suppressor screen using chemical mutagenesis Log phase culture of DY16154 were harvested and washed once with TM buffer (50 mM Tris-maleate), then 10 7 cells were resuspended in TM buffer containing 0.5 mg/ml MNNG (Sigma Aldrich). After 60 min incubation at room temperature, cells were washed once with TM buffer and plated on ETOP-containing plates. Colonies grown up on the plates were mated individually with DY18546 . 500 spores of each mating reaction were germinated on YES plates with or without ETOP to determine whether the ETOP resistance was due to single gene mutation (if a single gene mutation is the cause, colony number ratio should be approximately 1:2). If so, the colonies on the ETOP-containing plates were transferred to clonNAT-containing plates to determine whether the ETOP resistance was due to a top2 mutation (if it was due to a top2 mutation, all of the colonies should fail to grow on clonNAT-containing plates). By this criterion, about 50% of the suppressors were top2 mutations. The non-top2 mutations were identified by genome resequencing.
Protein extraction and immunoblotting
Protein extracts were made by treating cells with 1.85 M NaOH and 7.5% (v/v) b-mercaptoethanol followed by 55% (w/v) trichloroacetic acid (TCA, Sigma Aldrich). The antibodies used for immunoblotting were: anti-GST mouse monoclonal antibody (Abmart); antimCherry mouse monoclonal antibody (Huaxingbio); anti-GFP mouse monoclonal antibody (Roche); anti-HA mouse monoclonal antibody (MBL); anti-FLAG monoclonal antibody (Sigma Aldrich); streptavidin-peroxidase (Sigma Aldrich); anti-histone H3 (Abcam); peroxidase-anti-peroxidase (PAP, Sigma Aldrich); anti-SUMO rabbit polyclonal antibody (generated at NIBS antibody facility using recombinant Pmt3 as antigen).
Immunoprecipitation
About 100 OD600 units of cells were collected and washed twice with water. The cell pellet was mixed with 100 mL of lysis buffer (13PBS, 1 mM EDTA, 1 mM PMSF (Sigma Aldrich), 20 mM N-ethylmaleimide (NEM, Sigma Aldrich), 100 U DNase I (GE Healthcare), 0.05% NP-40, 13protease inhibitor cocktail (Roche), 10% glycerol) and 800 mL of 0.5 mm diameter glass beads. Bead beating lysis was performed using FastPrep-24 (MP Biomedicals). Then another 300 mL of lysis buffer was added, and the cell lysate was cleared by centrifugation at 13000 rpm for 30 min. The supernatant was incubated with tag-recognizing antibody beads, for example, GFPTrap agarose (Chromotek) for GFP fusion proteins and IgG Sepharose (GE Healthcare) for TAP-tagged proteins. After incubation, beads were washed 3 times with lysis buffer and eluted using SDS loading buffer.
Global profiling of SUMOylation sites
A fission yeast strain lacking endogenous Pmt3 (SUMO) and expressing His 10 - was cultured in YES medium. Four liters of culture were harvested at OD 600 2.0 and the cells were pelleted and resuspended in one volume of lysis buffer (0.1 M NaPO 4 , 0.01 M Tris, pH 8.0, 7 M guanidine-HCl). After cell lysis with cryogenic grinding, lysates were incubated with Ni-NTA agarose (QIAGEN) to pulldown Pmt3 conjugates. Pmt3 conjugates were digested with Lys-C/Trypsin/Asp-N and the resulting peptides were loaded on a strong cation exchange column (250 mm 3 2 cm, SCX, 5 mm) that are preceded by a reverse phase column (250 mm 3 2 cm, C18, 3 mm) and separated into six fractions by eluting with 5 mL 25 mM, 50 mM, 100 mM, 250 mM, 500 mM, and 1 M ammonium acetate. After desalting, each fraction was loaded onto a reverse-phase analytical column (75 mm 3 6 cm, C18, 10 mm) for LC-MS/MS using a Q-Exactive mass spectrometer interfaced with an Easy n1000 uHPLC system. The peptides were separated over a 90 min gradient from 100% buffer A (0.1% formic acid) to 30% buffer B (100% acetonitrile, 0.1% formic acid), followed by a 10 min gradient from 30% buffer B to 80% buffer B and maintained at 80% buffer B for 13 min. The MS parameters: top 30 most abundant ions selected for HCD dissociation; R = 140,000 in full scan, R = 17,500 in HCD scan; AGC targets = 1e 6 for full scan and 5e 4 for MS2; minimal signal threshold for MS2 = 4e 4 ; precursors of a charge state of +1, > +6 or unassigned were excluded (for 50 mM, 100 mM fraction, a technical repeat was obtained with +2 ions also excluded); normalized collision energy, 27; peptide match, preferred. The MS2 spectra, extracted using Rawxtract, were filtered for the presence of signature fragment ions (b 2+ 244.09339 m/z, b 3+ 357.1774 m/z, and b 5+ 557.25716 m/z) of DQIEAVLEQLGG, the remnant Pmt3 peptide after Lys-C/Trypsin/Asp-N digestion. SUMOylated peptides were identified as cross-linked peptide pairs using pLink (Yang et al., 2012) with the modification that for each candidate peptide pair, the sequence of one peptide is specified as DQIEAVLEQLGG. For each peptide pair, the E-values of both peptides were required to be < 0.001. The resulting FDR was 0.01 at the spectral level. The identified SUMOylated Top2 spectra were manually verified and annotated using pLabel (Yang et al., 2012) .
SIM(1-6)*) were expressed in fission yeast under the Pnmt1 promoter in EMM minimal medium for 24 hr. 2000 OD600 units of yeast cells were resuspended in lysis buffer (13PBS, 1 mM EDTA, 1 mM PMSF, 0.05% NP-40, 10% glycerol, 13protease inhibitor cocktail). Cell lysate was obtained by bead beating as mentioned above. After centrifugation for 30 min at 13000 rpm twice, supernatant was collected and incubated with 100 mL of anti-FLAG M2 affinity agarose gel (Sigma Aldrich) for 2 hr at 4 C. After binding, beads were briefly washed with lysis buffer and eluted with 33FLAG peptide.
In vitro Top2cc formation and reversion 0.1 mg of Top2-YFH was incubated with 0.3 mg of pDB4072, a plasmid containing alternating repeat of purine/pyrimidine sequence that constitutes a strong eukaryotic Top2 cleavage site (Spitzner et al., 1990) , and 10 mg of ETOP in 20 mL of reaction buffer (50 mM Tris-HCl, pH 7.5, 100 mM NaCl, 10 mM MgCl 2 , 5 mM ATP, 1 mM DTT, 0.2 mM CaCl 2 ). To release Top2 from DNA, 10 U of proteinase free DNase I was added and incubated at 30 C for 5 min. To examine the effect of Rrp2 on Top2cc level, immunopurified Rrp2 was added and incubated at 30 C for 10 min. For Top2cc reversion assay, Top2cc was formed by incubating 1 mg of GFP-tagged Top2-43SUMO, 3 mg of pDB4072 plasmid, and 50 mg of ETOP in 100 mL of reaction buffer, and then bound to 50 ml of GBP beads. After washing off ETOP, Top2cc reversion was allowed to occur in 200 mL of reaction buffer with or without 1 mg of Rrp2.
In vitro SUMOylaiton and ubiquitination
For in vitro SUMOylation of Top2, 0.1 mg of Top2-YFH was incubated with 0.1 mg of Rad31Fub2, 0.5 mg of Hus5, 0.5 mg of Pli1, and 1 mg of Pmt3-GG in 20 mL of reaction buffer (50 mM Tris-HCl, pH 7.5, 100 mM NaCl, 10 mM MgCl 2 , 5 mM ATP, 1 mM DTT, 0.2 mM CaCl 2 ) at 30 C for 10 min. For in vitro ubiquitination of Top2, 0.1 mg of Top2-YFH or Top2-43SUMO was incubated in reaction buffer with 0.1 mg of Uba1, 0.2 mg of Ubc4, 0.2 mg of Slx8 (wt or R247G), 0.2 mg of Rfp1 (wt or 2SIM*) or Rfp2, and 1 mg ubiquitin at 30 C for 10 min or 30 min.
For Rrp2 inhibiting Top2-43SUMO ubiquitination by STUbL, 0.1 mg of Top2-43SUMO was trapped on DNA by ETOP, and ubiquitination assay was reconstituted as above. Before adding Ub to start the ubiquitination reaction, 0.5 mg of immunopurified Rrp2 (Rrp2-wt, Rrp2-KA, or Rrp2-SIM(1-6)*) was added to the reaction mix and incubated at 30 C for 10 min. After all of the Top2cc SUMOylation and ubiquitination assay, 10 U of proteinase free DNase I was added and incubated at 30 C for 5 min. Reactions were stopped by SDS loading buffer and separated by NuPAGE gel (6% separation gel). For GST-43SUMO-LacI (GST-43PFH-LacI) ubiquitination, GST-43SUMO-LacI was purified from BL21. 0.1 mg of GST-43SUMO-LacI was incubated with 0.1 mg of lacO-repeat-containing plasmid pLD248 with or without 10 mM IPTG, and then ubiquitination assay was reconstituted as above.
GST pulldown
For Rfp1/2-Slx8 interaction, GST, GST-Rfp1, and GST-Rfp2 were expressed in BL21 and bound to glutathione Sepharose. Then the protein bound beads were incubated with HA-Slx8 (wt and R247G) in PBST (13PBS with 0.1% Tween-20) at 4 C for 2 hr. For poly-SUMO chain interaction, GST, GST-Rrp2, GST-Rrp2-N360 (wt, SIM3*, SIM5*, SIM3*+SIM5* and SIM(1-6)*), GST-Rrp2-N360D, GSTRfp1 (wt and 2SIM*), and GST-Rfp2 were expressed in Rosetta or BL21 and bound to glutathione Sepharose. Then the protein bound beads were incubated with purified poly-SUMO chains in PBST (13PBS with 0.1% Tween-20) at 4 C for 2 hr. Beads were washed 3 times in PBST and subsequently eluted by SDS loading buffer. For in vitro SUMOylation followed by GST pulldown, Top2 was SUMOylated as described above. Then SUMOylation system were diluted five-fold in PBST and incubated at 4 C for 2 hr with GST, GST-Rrp2, GST-Rrp2-N360, or GST-Rrp2-N360D, which had been bound on the glutathione-Sepharose beads. Then beads were washed 3 times in PBST and subsequently eluted by SDS loading buffer.
DNA pulldown and Rrp2 displacement assay
For DNA pulldown analysis, a biotinylated 100-bp-long DNA fragment was amplified by PCR from amp gene in pDUAL (primers: Biotin-AAGTTCTGCTATGTGGCGCGGTATTA and ACTGGTGAGTACTCAACCAAGTCAT) and purified by ethanol precipitation. The STUbL complex was pre-assembled by mixing 1mg of HA-Slx8 (wt and R247G) with 1mg of HA-GST-Rfp1 in 100 ml of binding buffer (100 mM NaCl, 1 mM EDTA, 10% glycerol, 0.05% NP-40, 1 mM PMSF, 1 mM DTT, 13protease inhibitor cocktail) at 4 C for 1 hr. And 1 mg of biotinylated DNA was pre-bound on 10 ml of streptavidin Dynabeads (Thermo Fischer) in 100 ml of binding buffer at 4 C for 1 hr, then the STUbL complex and DNA-Dynabeads were mixed and incubated at 4 C for 2 hr. The STUbL-DNA complexes on Dynabeads were washed 3 times followed by elution in SDS loading buffer.
For the experiment examining the ability of Rrp2 to displaced SUMOylated Top2-Y835F from DNA, a biotinylated 500-bp-long DNA fragment was amplified by PCR from amp gene in pDUAL (primers: Biotin-AAGTTCTGCTATGTGGCGCGGTATTA and GCTCACCGGCTCCAGATTTATCAGCA) and purified by ethanol precipitation. 0.5 mg of Top2-Y835F-YFH, 1 mg of biotinylated DNA and 10 ml of streptavidin Dynabeads were mixed and incubated in 100 ml of binding buffer at 4 C for 1 hr. Then Top2-Y835F bound to DNA-coated Dynabeads was SUMOylated at 30 C for 10 min with the recombinant SUMOylation system. After washing off SUMOylation enzyme, Dynabeads were incubated with immunopurified Rrp2 in 40 ml of displacement buffer (20 mM Tris-HCl, pH 7.5, 100 mM NaCl, 10 mM MgCl 2 , 0.1 mg/ml BSA, 1 mM DTT, 10% glycerol, 5 mM ATP or ATP-gS) at 30 C for 15 min.
